| Original language | English |
|---|---|
| Pages (from-to) | 52-56 |
| Number of pages | 5 |
| Journal | Thrombosis Research |
| Volume | 204 |
| DOIs | |
| State | Published - Aug 2021 |
Bibliographical note
Funding Information:We appreciate the support and collaboration of the co-investigators participating in COMMAND VTE Registry and RIETE Registry. We are indebted to the independent clinical research organization (Research Institute for Production Development, Kyoto, Japan) for the COMMAND VTE Registry through technical support. We also thank the RIETE Registry Coordinating Center, S&H Medical Science Service, for their quality control data, logistic and administrative support and Prof. Salvador Ortiz, Universidad Autónoma Madrid and Silvia Galindo, both Statistical Advisors in S&H Medical Science Service for the statistical analysis of the data presented in this paper. The COMMAND VTE Registry is supported by the independent clinical research organization (Research Institute for Production Development, Kyoto, Japan) and research funding from Mitsubishi Tanabe Pharma Corporation. We express our gratitude to Sanofi Spain for supporting the RIETE Registry with an unrestricted educational grant. The research funding had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Dr. Yamashita received lecture fees from Daiichi-Sankyo, Bristol-Myers Squibb, Pfizer, and Bayer Healthcare. Dr. Bikdeli reports that he is a consulting expert (on behalf of the plaintiff) for litigation related to a specific type of inferior vena cava filters. Dr. Monreal received non-restricted research grants from Sanofi and Bayer, and lecture fees from Sanofi, Daiichi-Sankyo and Leo Pharma. Dr. Morimoto received lecture fees from Mitsubishi Tanabe Pharma and Pfizer Japan and consultant fees from Asahi Kasei, Bristol-Myers Squibb, and Boston Scientific. Dr. López received lectures fees from Bristol-Myers Squibb and Rovi. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Funding Information:
The COMMAND VTE Registry is supported by the independent clinical research organization (Research Institute for Production Development, Kyoto, Japan) and research funding from Mitsubishi Tanabe Pharma Corporation . We express our gratitude to Sanofi Spain for supporting the RIETE Registry with an unrestricted educational grant. The research funding had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Funding
We appreciate the support and collaboration of the co-investigators participating in COMMAND VTE Registry and RIETE Registry. We are indebted to the independent clinical research organization (Research Institute for Production Development, Kyoto, Japan) for the COMMAND VTE Registry through technical support. We also thank the RIETE Registry Coordinating Center, S&H Medical Science Service, for their quality control data, logistic and administrative support and Prof. Salvador Ortiz, Universidad Autónoma Madrid and Silvia Galindo, both Statistical Advisors in S&H Medical Science Service for the statistical analysis of the data presented in this paper. The COMMAND VTE Registry is supported by the independent clinical research organization (Research Institute for Production Development, Kyoto, Japan) and research funding from Mitsubishi Tanabe Pharma Corporation. We express our gratitude to Sanofi Spain for supporting the RIETE Registry with an unrestricted educational grant. The research funding had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Dr. Yamashita received lecture fees from Daiichi-Sankyo, Bristol-Myers Squibb, Pfizer, and Bayer Healthcare. Dr. Bikdeli reports that he is a consulting expert (on behalf of the plaintiff) for litigation related to a specific type of inferior vena cava filters. Dr. Monreal received non-restricted research grants from Sanofi and Bayer, and lecture fees from Sanofi, Daiichi-Sankyo and Leo Pharma. Dr. Morimoto received lecture fees from Mitsubishi Tanabe Pharma and Pfizer Japan and consultant fees from Asahi Kasei, Bristol-Myers Squibb, and Boston Scientific. Dr. López received lectures fees from Bristol-Myers Squibb and Rovi. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The COMMAND VTE Registry is supported by the independent clinical research organization (Research Institute for Production Development, Kyoto, Japan) and research funding from Mitsubishi Tanabe Pharma Corporation . We express our gratitude to Sanofi Spain for supporting the RIETE Registry with an unrestricted educational grant. The research funding had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
| Funders | Funder number |
|---|---|
| Asahi Kasei | |
| S&H Medical Science Service | |
| Universidad Autónoma Madrid and Silvia Galindo | |
| Bristol-Myers Squibb | |
| Pfizer | |
| Bayer | |
| Sanofi | |
| Bayer HealthCare | |
| LEO Pharma Research Foundation | |
| Mitsubishi Tanabe Pharma Corporation |
Keywords
- Asians
- Prognosis
- Pulmonary embolism
- Race
- White